[1]
Gordon, K., Eyerich, K., Anadkat, M., Choon, S.E., Elewski, B., Barker, J., Mostaghimi, A., Tang, M., Haeufel, T., Thoma, C. and Thaci, D. 2024. Low Occurrence of Predefined Safety Events Across Six Randomized Clinical Trials of Spesolimab in Dermatologic Conditions. SKIN The Journal of Cutaneous Medicine. 8, 4 (Jul. 2024), s410. DOI:https://doi.org/10.25251/skin.8.supp.410.